Name | Datopotamab |
---|
Description | Datopotamab (CDP7657) is an antibody targeting to TROP2. Datopotamab can be used to synthesize Datopotamab deruxtecan (HY-141598), TROP2-directed antibody-drug conjugate (ADC). Datopotamab deruxtecan consists of DNA topoisomerase I inhibitor Deruxtecan (HY-13631E) and Datopotamab[1]. |
---|---|
Related Catalog | |
Target |
TROP2[1] |
References |
No Any Chemical & Physical Properties |